<p>Norden Group LLC 在最近向证券交易委员会（SEC）提交的 13F 表格中表示，在第三季度将其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的持股减少了 76.3%。该机构投资者在此期间出售了 4,226 股后，持有该医疗研究公司 1,315 股股票。Norden Group LLC 在赛默飞世尔的持股在最近一个季度末的价值为 638,000 美元。</p>
<ul>
<li>行业轮动：2026 年的 2 个聪明资金动向</li>
</ul>
<p>其他对冲基金最近也调整了对该公司的持股。Heathbridge Capital Management Ltd. 在第三季度新购入了约 230,000 美元的赛默飞世尔股份。Triangle Securities Wealth Management 在第三季度将其在赛默飞世尔的持股增加了 5.2%。Triangle Securities Wealth Management 目前持有 2,805 股该医疗研究公司的股票，价值 1,360,000 美元，此前在上个季度又购买了 139 股。Founders Financial Securities LLC 在第三季度将其在赛默飞世尔的持股增加了 11.1%。Founders Financial Securities LLC 目前持有 2,367 股该医疗研究公司的股票，价值 1,148,000 美元，此前在上个季度又购买了 237 股。Cape ANN Savings Bank 在第三季度新购入了约 210,000 美元的赛默飞世尔股份。最后，Value Partners Investments Inc. 在第三季度将其在赛默飞世尔的持股增加了 1.6%。Value Partners Investments Inc. 目前持有 10,440 股该医疗研究公司的股票，价值 5,061,000 美元，此前在上个季度又购买了 160 股。目前，89.23% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师设定新目标价</h2>
<p>几位股票研究分析师最近对该公司发表了看法。花旗集团将赛默飞世尔的评级从 “中性” 上调至 “买入”，并在 12 月 11 日的研究报告中将其目标价从 580.00 美元上调至 660.00 美元。KeyCorp 将赛默飞世尔的评级从 “行业权重” 上调至 “超配”，并在 12 月 7 日的研究报告中设定了 750.00 美元的目标价。汇丰全球研究在 12 月 1 日的报告中将赛默飞世尔的评级从 “持有” 上调至 “强力买入”。瑞银集团在 10 月 23 日的报告中将赛默飞世尔的目标价从 500.00 美元上调至 590.00 美元，并给予该股票 “中性” 评级。最后，TD Cowen 在 10 月 23 日的报告中将赛默飞世尔的目标价从 612.00 美元上调至 654.00 美元，并给予公司 “买入” 评级。一位分析师给予该股票 “强力买入” 评级，二十位给予 “买入” 评级，三位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 616.60 美元。</p>
<ul>
<li>机构热爱这 3 家公司，你也应该吗？</li>
</ul>
<p><strong>查看我们关于赛默飞世尔的最新报告</strong></p>
<h2>赛默飞世尔的内部交易</h2>
<p>在相关消息中，副总裁 Lisa P. Britt 于 11 月 7 日星期五出售了 10,225 股公司的股票，交易平均价格为 571.62 美元，总价值为 5,844,814.50 美元。出售完成后，该副总裁持有 14,145 股公司的股票，价值约为 8,085,564.90 美元。此次交易使其持股减少了 41.96%。该出售在 SEC 的备案中披露，您可以通过此链接访问。此外，执行副总裁 Michael D. Shafer 于 11 月 25 日星期二出售了 10,725 股公司的股票，交易平均价格为 600.00 美元，总交易额为 6,435,000.00 美元。交易完成后，该执行副总裁直接持有 18,731 股公司的股票，价值约为 11,238,600 美元。此次交易使其持股减少了 36.41%。该出售的披露信息可在 SEC 的备案中找到。在过去的九十天里，内部人士已出售 149,271 股公司股票，价值 86,507,282 美元。公司内部人士持有 0.33% 的公司股票。</p>
<h2>赛默飞世尔股票上涨 0.3%</h2>
<ul>
<li>这 3 只股票正在利用回购来传达市场信心</li>
</ul>
<p>NYSE:TMO 周五开盘价为 580.65 美元。该股票的市值为 2181.6 亿美元，市盈率为 33.54，市盈增长比率为 4.11，贝塔系数为 0.90。赛默飞世尔的 52 周低点为 385.46 美元，52 周高点为 610.97 美元。该公司的债务与股本比率为 0.62，流动比率为 1.50，速动比率为 1.11。该股票的 50 日移动平均线为 573.94 美元，200 日移动平均线为 502.88 美元。</p>
<p>赛默飞世尔（NYSE:TMO - 获取免费报告）最近于 10 月 22 日星期三发布了季度财报。该医疗研究公司报告该季度每股收益为 5.79 美元，超出市场共识预期的 5.50 美元，超出幅度为 0.29 美元。该公司在该季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。赛默飞世尔的净利润率为 15.02%，股本回报率为 16.97%。该公司的季度收入较去年同期增长了 4.9%。去年同期，该公司每股收益为 5.28 美元。赛默飞世尔已将其 2025 财年的指导目标设定为每股收益 22.600-22.860 美元。整体来看，股票研究分析师预测赛默飞世尔在当前财年将发布每股收益 23.28 美元。</p>
<h2>赛默飞世尔分红公告</h2>
<p>该公司最近还披露了季度股息，将于 1 月 15 日（星期四）支付。12 月 15 日（星期一）登记的投资者将获得每股 0.43 美元的股息。这相当于每年 1.72 美元的股息和 0.3% 的股息收益率。除息日期为 12 月 15 日（星期一）。赛默飞世尔的股息支付比率（DPR）目前为 9.94%。</p>
<p>赛默飞世尔宣布，其董事会于 11 月 6 日（星期四）启动了一项股票回购计划，允许公司回购 50 亿美元的股份。该回购授权允许这家医疗研究公司通过公开市场购买最多 2.4% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>赛默飞世尔简介</h2>
<p>（免费报告）</p>
<p>赛默飞世尔（NYSE: TMO）是一家全球科学仪器、试剂和耗材、软件及服务的提供商，支持研究、临床和工业实验室。该公司提供分析仪器和实验室设备、生命科学试剂和试剂盒、专业诊断以及研究人员、临床医生和制造商使用的广泛耗材。其产品还包括实验室信息管理和数据分析软件，以及帮助客户高效运行复杂工作流程的服务解决方案，如仪器维护、验证和物流。</p>
<p>赛默飞世尔通过多个业务领域运营，广泛涵盖生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务，包括为制药和生物技术公司提供的合同开发和制造服务。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比赛默飞世尔更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><strong>想看看其他对 TMO 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取赛默飞世尔公司（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在赛默飞世尔吗？</h2>
<p>在考虑赛默飞世尔之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而赛默飞世尔并不在名单上。</p>
<p>虽然赛默飞世尔目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

赛默飞世尔

<p>Norden Group LLC 在第三季度将其在赛默飞世尔的持股减少了 76.3%，目前持有 1,315 股，价值 63.8 万美元。其他对冲基金也调整了其持股，分析师提高了价格目标和评级。内部交易方面，副总裁 Lisa P. Britt 和执行副总裁 Michael D. Shafer 进行了大量股票出售。该股票开盘价为 580.65 美元，市值为 2181.6 亿美元</p>

<p>Norden Group LLC decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 76.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,315 shares of the medical research company's stock after selling 4,226 shares during the period. Norden Group LLC's holdings in Thermo Fisher Scientific were worth $638,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Norden Group LLC 在最近向证券交易委员会（SEC）提交的 13F 表格中表示，在第三季度将其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的持股减少了 76.3%。该机构投资者在此期间出售了 4,226 股后，持有该医疗研究公司 1,315 股股票。Norden Group LLC 在赛默飞世尔的持股在最近一个季度末的价值为 638,000 美元。</p>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的 2 个聪明资金动向</li>
</ul>
</div><p>Other hedge funds also recently modified their holdings of the company. Heathbridge Capital Management Ltd. acquired a new position in Thermo Fisher Scientific during the third quarter worth about $230,000. Triangle Securities Wealth Management boosted its position in shares of Thermo Fisher Scientific by 5.2% during the 3rd quarter. Triangle Securities Wealth Management now owns 2,805 shares of the medical research company's stock valued at $1,360,000 after purchasing an additional 139 shares in the last quarter. Founders Financial Securities LLC raised its holdings in shares of Thermo Fisher Scientific by 11.1% in the 3rd quarter. Founders Financial Securities LLC now owns 2,367 shares of the medical research company's stock worth $1,148,000 after purchasing an additional 237 shares in the last quarter. Cape ANN Savings Bank acquired a new stake in Thermo Fisher Scientific during the third quarter valued at approximately $210,000. Finally, Value Partners Investments Inc. grew its position in Thermo Fisher Scientific by 1.6% in the third quarter. Value Partners Investments Inc. now owns 10,440 shares of the medical research company's stock worth $5,061,000 after buying an additional 160 shares during the last quarter. 89.23% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他对冲基金最近也调整了对该公司的持股。Heathbridge Capital Management Ltd. 在第三季度新购入了约 230,000 美元的赛默飞世尔股份。Triangle Securities Wealth Management 在第三季度将其在赛默飞世尔的持股增加了 5.2%。Triangle Securities Wealth Management 目前持有 2,805 股该医疗研究公司的股票，价值 1,360,000 美元，此前在上个季度又购买了 139 股。Founders Financial Securities LLC 在第三季度将其在赛默飞世尔的持股增加了 11.1%。Founders Financial Securities LLC 目前持有 2,367 股该医疗研究公司的股票，价值 1,148,000 美元，此前在上个季度又购买了 237 股。Cape ANN Savings Bank 在第三季度新购入了约 210,000 美元的赛默飞世尔股份。最后，Value Partners Investments Inc. 在第三季度将其在赛默飞世尔的持股增加了 1.6%。Value Partners Investments Inc. 目前持有 10,440 股该医疗研究公司的股票，价值 5,061,000 美元，此前在上个季度又购买了 160 股。目前，89.23% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several equities research analysts have recently weighed in on the company. Citigroup raised Thermo Fisher Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price objective for the stock from $580.00 to $660.00 in a research note on Thursday, December 11th. KeyCorp raised Thermo Fisher Scientific from a &#34;sector weight&#34; rating to an &#34;overweight&#34; rating and set a $750.00 price target on the stock in a research note on Sunday, December 7th. Hsbc Global Res upgraded Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Monday, December 1st. UBS Group raised their target price on shares of Thermo Fisher Scientific from $500.00 to $590.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, October 23rd. Finally, TD Cowen boosted their price target on shares of Thermo Fisher Scientific from $612.00 to $654.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $616.60.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该公司发表了看法。花旗集团将赛默飞世尔的评级从 “中性” 上调至 “买入”，并在 12 月 11 日的研究报告中将其目标价从 580.00 美元上调至 660.00 美元。KeyCorp 将赛默飞世尔的评级从 “行业权重” 上调至 “超配”，并在 12 月 7 日的研究报告中设定了 750.00 美元的目标价。汇丰全球研究在 12 月 1 日的报告中将赛默飞世尔的评级从 “持有” 上调至 “强力买入”。瑞银集团在 10 月 23 日的报告中将赛默飞世尔的目标价从 500.00 美元上调至 590.00 美元，并给予该股票 “中性” 评级。最后，TD Cowen 在 10 月 23 日的报告中将赛默飞世尔的目标价从 612.00 美元上调至 654.00 美元，并给予公司 “买入” 评级。一位分析师给予该股票 “强力买入” 评级，二十位给予 “买入” 评级，三位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 616.60 美元。</p>
</div><ul>
<li>Institutions Love These 3 Companies, Should You As Well?</li>
</ul>
<div class="lb-trans"><ul>
<li>机构热爱这 3 家公司，你也应该吗？</li>
</ul>
</div><p><strong>Check Out Our Latest Report on Thermo Fisher Scientific</strong></p>
<div class="lb-trans"><p><strong>查看我们关于赛默飞世尔的最新报告</strong></p>
</div><h2>Insider Transactions at Thermo Fisher Scientific</h2>
<div class="lb-trans"><h2>赛默飞世尔的内部交易</h2>
</div><p>In related news, VP Lisa P. Britt sold 10,225 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $571.62, for a total value of $5,844,814.50. Following the completion of the sale, the vice president owned 14,145 shares of the company's stock, valued at approximately $8,085,564.90. The trade was a 41.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael D. Shafer sold 10,725 shares of the firm's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $600.00, for a total transaction of $6,435,000.00. Following the transaction, the executive vice president directly owned 18,731 shares in the company, valued at approximately $11,238,600. The trade was a 36.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 149,271 shares of company stock valued at $86,507,282. Corporate insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，副总裁 Lisa P. Britt 于 11 月 7 日星期五出售了 10,225 股公司的股票，交易平均价格为 571.62 美元，总价值为 5,844,814.50 美元。出售完成后，该副总裁持有 14,145 股公司的股票，价值约为 8,085,564.90 美元。此次交易使其持股减少了 41.96%。该出售在 SEC 的备案中披露，您可以通过此链接访问。此外，执行副总裁 Michael D. Shafer 于 11 月 25 日星期二出售了 10,725 股公司的股票，交易平均价格为 600.00 美元，总交易额为 6,435,000.00 美元。交易完成后，该执行副总裁直接持有 18,731 股公司的股票，价值约为 11,238,600 美元。此次交易使其持股减少了 36.41%。该出售的披露信息可在 SEC 的备案中找到。在过去的九十天里，内部人士已出售 149,271 股公司股票，价值 86,507,282 美元。公司内部人士持有 0.33% 的公司股票。</p>
</div><h2>Thermo Fisher Scientific Trading Up 0.3%</h2>
<div class="lb-trans"><h2>赛默飞世尔股票上涨 0.3%</h2>
</div><ul>
<li>These 3 Stocks Are Using Buybacks to Signal Market Confidence</li>
</ul>
<div class="lb-trans"><ul>
<li>这 3 只股票正在利用回购来传达市场信心</li>
</ul>
</div><p>NYSE:TMO opened at $580.65 on Friday. The stock has a market cap of $218.16 billion, a PE ratio of 33.54, a price-to-earnings-growth ratio of 4.11 and a beta of 0.90. Thermo Fisher Scientific Inc. has a fifty-two week low of $385.46 and a fifty-two week high of $610.97. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.50 and a quick ratio of 1.11. The stock's 50-day moving average is $573.94 and its two-hundred day moving average is $502.88.</p>
<div class="lb-trans"><p>NYSE:TMO 周五开盘价为 580.65 美元。该股票的市值为 2181.6 亿美元，市盈率为 33.54，市盈增长比率为 4.11，贝塔系数为 0.90。赛默飞世尔的 52 周低点为 385.46 美元，52 周高点为 610.97 美元。该公司的债务与股本比率为 0.62，流动比率为 1.50，速动比率为 1.11。该股票的 50 日移动平均线为 573.94 美元，200 日移动平均线为 502.88 美元。</p>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The medical research company reported $5.79 EPS for the quarter, topping the consensus estimate of $5.50 by $0.29. The business had revenue of $11.12 billion during the quarter, compared to analysts' expectations of $10.90 billion. Thermo Fisher Scientific had a net margin of 15.02% and a return on equity of 16.97%. The firm's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period last year, the company posted $5.28 earnings per share. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. As a group, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>赛默飞世尔（NYSE:TMO - 获取免费报告）最近于 10 月 22 日星期三发布了季度财报。该医疗研究公司报告该季度每股收益为 5.79 美元，超出市场共识预期的 5.50 美元，超出幅度为 0.29 美元。该公司在该季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。赛默飞世尔的净利润率为 15.02%，股本回报率为 16.97%。该公司的季度收入较去年同期增长了 4.9%。去年同期，该公司每股收益为 5.28 美元。赛默飞世尔已将其 2025 财年的指导目标设定为每股收益 22.600-22.860 美元。整体来看，股票研究分析师预测赛默飞世尔在当前财年将发布每股收益 23.28 美元。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>赛默飞世尔分红公告</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, December 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.94%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，将于 1 月 15 日（星期四）支付。12 月 15 日（星期一）登记的投资者将获得每股 0.43 美元的股息。这相当于每年 1.72 美元的股息和 0.3% 的股息收益率。除息日期为 12 月 15 日（星期一）。赛默飞世尔的股息支付比率（DPR）目前为 9.94%。</p>
</div><p>Thermo Fisher Scientific announced that its board has initiated a stock repurchase plan on Thursday, November 6th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the medical research company to reacquire up to 2.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>赛默飞世尔宣布，其董事会于 11 月 6 日（星期四）启动了一项股票回购计划，允许公司回购 50 亿美元的股份。该回购授权允许这家医疗研究公司通过公开市场购买最多 2.4% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>赛默飞世尔简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Thermo Fisher Scientific NYSE: TMO is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.</p>
<div class="lb-trans"><p>赛默飞世尔（NYSE: TMO）是一家全球科学仪器、试剂和耗材、软件及服务的提供商，支持研究、临床和工业实验室。该公司提供分析仪器和实验室设备、生命科学试剂和试剂盒、专业诊断以及研究人员、临床医生和制造商使用的广泛耗材。其产品还包括实验室信息管理和数据分析软件，以及帮助客户高效运行复杂工作流程的服务解决方案，如仪器维护、验证和物流。</p>
</div><p>Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.</p>
<div class="lb-trans"><p>赛默飞世尔通过多个业务领域运营，广泛涵盖生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务，包括为制药和生物技术公司提供的合同开发和制造服务。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比赛默飞世尔更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 TMO 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取赛默飞世尔公司（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在赛默飞世尔吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑赛默飞世尔之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而赛默飞世尔并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然赛默飞世尔目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Norden Group LLC 减少了其在赛默飞世尔公司 $TMO 的持股